Erx


Don’t Let 2033 Fool You: The NDC 12 Transition Will Take Years to Navigate

Seven years can sound like plenty of time to prepare for a regulatory change. When that change affects an identifier embedded across pharmacy, medical claims, reimbursement,...

Prescribing Clarity Isn’t Optional: Why Life Sciences Teams Should Care About Electronic Prescription Precision

For pharmaceutical manufacturers and life sciences organizations, ensuring patients use medications as intended is central to outcomes, safety, and adherence. But when EHR...

DTx Workshop Brought Diverse Views on Meeting Demand Through Normalized Dispensing & Reimbursement

I recently attended a Digital Therapeutics (DTx) workflow workshop sponsored by the Digital Therapeutics Alliance and the National Council for Prescription Drug Programs (NCPDP)....

  • 1